‘Apples And Oranges’: EMA Cautions Against FDA Comparisons As It Moves To Shorten Reviews

 
• By Eliza Slawther
  
Comparing the EMA and US FDA is like comparing apples to oranges, a senior EMA figure says (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU Pharma Legislation Reform

More from EMA